Advertisement
ABT vs STE
Which Stock Would AI Choose? Abbott Laboratories (ABT) vs. STERIS plc (STE) Stock Comparison
Key Takeaways
- ABT and STE are both healthcare equipment companies facing recent price pressure, with ABT showing a larger market capitalization and broader product portfolio.
- Recent market activity indicates ABT traded near $102.61 while STE traded near $205.04, reflecting declines over the past month amid sector-wide sentiment.
- ABT benefits from diversified exposure across diagnostics, nutrition, and devices, whereas STE focuses primarily on sterilization and infection prevention solutions.
- Both stocks have delivered dividends recently, with ABT maintaining a long streak of consecutive quarterly payouts and STE announcing its latest distribution.
- Relative performance shows comparable year-to-date weakness, though ABT maintains greater scale and analyst coverage.
- Sector exposure remains healthcare equipment for both, with shared sensitivity to regulatory developments and healthcare spending trends.
Introduction
This comparison examines ABT (Abbott Laboratories) and STE (STERIS plc), two established players in the healthcare equipment sector. Investors and traders seeking to understand relative positioning within medical devices and related services may find this analysis useful. The review focuses on observable factors such as recent price behavior, business models, and market sentiment drawn from public financial sources. It provides a neutral framework for evaluating contrasts in scale, growth drivers, and risk profiles without offering recommendations.
ABT Overview and Recent Performance
Abbott Laboratories operates across diagnostics, medical devices, nutrition, and established pharmaceuticals. Its diversified model supports resilience across multiple healthcare segments. In recent market activity, ABT shares traded around $102.61, reflecting pressure over the past month with declines near 9-12 percent amid broader sector movements. Key developments include a declared quarterly dividend marking the company's 411st consecutive payout and resolution of certain infant formula-related claims. Sentiment has been influenced by these corporate actions alongside ongoing healthcare utilization trends, contributing to a measured trading range in recent weeks.
STE Overview and Recent Performance
STERIS plc specializes in infection prevention, sterilization, and procedural products for healthcare and life sciences markets. The company maintains a focused portfolio centered on critical support services for medical facilities. In recent market activity, STE shares traded around $205.04, showing declines of approximately 11-13 percent over the past month consistent with sector patterns. Recent developments include a quarterly dividend announcement and steady operational performance in its core segments. Market sentiment reflects attention to healthcare infrastructure spending and regulatory environments, resulting in comparable recent price behavior without standout catalysts in the immediate period.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of AI trading bots optimized for prevailing market conditions. The platform offers hundreds of AI trading bots that trade thousands of different tickers, employing varied strategies, timeframes, and performance profiles. Only those demonstrating strong suitability through metrics such as win rates often in the 59-67 percent range and annualized returns frequently exceeding 100 percent in live conditions earn placement in the trending section. These bots differ widely in approach, from short-term momentum to multi-ticker trend following, allowing users to explore options aligned with specific objectives. Review the full selection at Trending AI Robots for detailed statistics.
Head-to-Head Comparison
ABT and STE operate in overlapping healthcare equipment spaces yet differ in scale and diversification. ABT maintains a significantly larger market capitalization near $177 billion compared to STE near $20 billion, supporting broader revenue streams across multiple categories. Growth drivers for ABT include device innovation and nutritional products, while STE emphasizes procedural and sterilization solutions with more concentrated exposure. Recent momentum shows both experiencing similar downward pressure in the past month, though ABT exhibits lower beta indicating relatively greater stability. Risk factors include regulatory and litigation elements more prominently noted for ABT, versus operational concentration for STE. Market sentiment remains tied to healthcare spending cycles for both, creating trade-offs between ABT’s diversification and STE’s specialized positioning.
Tickeron AI Verdict
Based on observable factors including trend consistency, scale, and relative positioning, Tickeron’s AI models would currently assign a probabilistic edge to ABT over STE. The larger capitalization and diversified business lines provide a buffer in recent market activity, alongside sustained dividend history. Both equities show comparable recent weakness, yet ABT’s broader exposure may support more stable signals in current conditions. This assessment reflects pattern recognition rather than certainty and remains subject to evolving data.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Hold and STE is a StrongBuy.
ABT | STE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 65 | 6 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 96 | |
SMR RATING 1..100 | 68 | 66 | |
PRICE GROWTH RATING 1..100 | 58 | 59 | |
P/E GROWTH RATING 1..100 | 7 | 78 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ABT's Valuation (4) in the Medical Specialties industry is in the same range as STE (8). This means that ABT’s stock grew similarly to STE’s over the last 12 months.
STE's Profit vs Risk Rating (96) in the Medical Specialties industry is in the same range as ABT (100). This means that STE’s stock grew similarly to ABT’s over the last 12 months.
STE's SMR Rating (66) in the Medical Specialties industry is in the same range as ABT (68). This means that STE’s stock grew similarly to ABT’s over the last 12 months.
ABT's Price Growth Rating (58) in the Medical Specialties industry is in the same range as STE (59). This means that ABT’s stock grew similarly to STE’s over the last 12 months.
ABT's P/E Growth Rating (7) in the Medical Specialties industry is significantly better than the same rating for STE (78). This means that ABT’s stock grew significantly faster than STE’s over the last 12 months.
| ABT | STE | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 57% | 2 days ago 77% |
| Stochastic ODDS (%) | 2 days ago 44% | 2 days ago 56% |
| Momentum ODDS (%) | 2 days ago 55% | 2 days ago 52% |
| MACD ODDS (%) | 4 days ago 59% | 2 days ago 62% |
| TrendWeek ODDS (%) | 2 days ago 53% | 2 days ago 52% |
| TrendMonth ODDS (%) | 2 days ago 55% | 2 days ago 53% |
| Advances ODDS (%) | 10 days ago 57% | 4 days ago 49% |
| Declines ODDS (%) | 2 days ago 55% | 2 days ago 57% |
| BollingerBands ODDS (%) | 2 days ago 41% | 2 days ago 49% |
| Aroon ODDS (%) | 2 days ago 57% | 2 days ago 44% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABT’s FA Score shows that 2 FA rating(s) are green while STE’s FA Score has 1 green FA rating(s).
- ABT’s FA Score: 2 green, 3 red.
- STE’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABT’s TA Score shows that 5 TA indicator(s) are bullish while STE’s TA Score has 5 bullish TA indicator(s).
- ABT’s TA Score: 5 bullish, 6 bearish.
- STE’s TA Score: 5 bullish, 5 bearish.
Price Growth
ABT (@Medical/Nursing Services) experienced а -4.50% price change this week, while STE (@Medical/Nursing Services) price change was +0.01% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.00%. For the same industry, the average monthly price growth was -5.06%, and the average quarterly price growth was -2.61%.
Reported Earning Dates
ABT is expected to report earnings on Oct 21, 2026.
STE is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical/Nursing Services (-2.00% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
ABT and
Correlation & Price change
A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.